TokenPost·
Cardiol Therapeutics Sets Up $75 Million Share-Sale Program
The company plans to use proceeds to support development of CardiolRx for recurrent pericarditis.
Every crypto headline. One feed. Updated every minute.
The company plans to use proceeds to support development of CardiolRx for recurrent pericarditis.